ArticlePloS one2023

CCX559 is a potent, orally-administered small molecule PD-L1 inhibitor that induces anti-tumor immunity.

Kathleen M C Sullivan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.